Home › Phases › Approved

Approved (29 companies)

Companies with at least one active program at Approved.

Ticker	Company	Therapeutic areas	Approved programs	Lead stage	Programs
ADCT	ADC Therapeutics	Oncology	1	Approved	5
ADMA	Adma Biologics	Infectious Disease	3	Approved	4
AKBA	Akebia Therapeutics	HematologyOphthalmology+2 Rare	3	Approved	10
ANAB	AnaptysBio	DermatologyGI/Hepatology+2 Rare	1	Approved	6
ARDX	Ardelyx	Renal	2	Approved	4
ARVN	Arvinas	NeurologyOncology Rare	1	Approved	15
AUTL	Autolus Therapeutics	HematologyImmunology+3 Rare	1	Approved	12
CLRB	Cellectar Biosciences	Oncology	3	Approved	11
CHRS	Coherus Oncology	Oncology	1	Approved	4
CRNX	Crinetics Pharmaceuticals	MetabolicOncology Rare	1	Approved	6
ETON	Eton Pharmaceuticals	GI/HepatologyMetabolic+1 Rare	6	Approved	14
EXEL	Exelixis	CardiovascularOncology	7	Approved	21
FBIO	Fortress Biotech	DermatologyHematology+1 Rare	5	Approved	12
GERN	Geron	Oncology	1	Approved	3
KURA	Kura Oncology	MetabolicOncology	1	Approved	9
IRD	Opus Genetics	Ophthalmology Rare	1	Approved	12
RYTM	Rhythm Pharmaceuticals	Metabolic Rare	3	Approved	13
RCKT	Rocket Pharmaceuticals	CardiovascularImmunology Rare	1	Approved	4
SRPT	Sarepta Therapeutics	Neurology Rare	4	Approved	10
SCYX	Scynexis	Infectious Disease	1	Approved	4
TGTX	Tg Therapeutics	Neurology Rare	1	Approved	4
TVTX	Travere Therapeutics	MetabolicRenal Rare	3	Approved	7
RARE	Ultragenyx Pharmaceutical	CardiovascularGI/Hepatology+2 Rare	5	Approved	12
QURE	uniQure	HematologyMetabolic+1 Rare	1	Approved	6
VNDA	Vanda Pharmaceuticals	CardiovascularDermatology+6 Rare	7	Approved	26
VERA	Vera Therapeutics	Infectious DiseaseRenal Rare	1	Approved	8
VRDN	Viridian Therapeutics	Ophthalmology	1	Approved	6
XNCR	Xencor	HematologyImmunology+4 Rare	6	Approved	30
ZYME	Zymeworks	OncologyRespiratory	1	Approved	11